Literature DB >> 20862591

An additional long-term mechanism of NF-κB regulation after cytokine treatment in a human hepatoma cell line.

Patricia Kohlhof1.   

Abstract

The eukaryotic transcription factor nuclear factor-κB (NF-κB) is mainly involved in the regulation of immune response and inflammation. A prolonged activation of NF-κB has been reported in context with chronic diseases. What leads to a prolongation of NF-κB activity is not well understood. Here, an increase in total intracellular NF-κB protein and mRNA levels as well as a temporary colocalization of NF-κB with proteasomes in human hepatocytes after treatment with TNF-α or IL-1β is reported. This indicates that beside an instantaneous activation of NF-κB and partly autoregulated inactivation by breakdown and synthesis of the inhibitors of NF-κB (IκBs), there are also mechanisms for a long-term regulation by de novo-synthesis and degradation of NF-κB protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20862591     DOI: 10.1007/s00428-010-0970-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  47 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  The tumor suppressor activity of SOCS-1.

Authors:  Robert Rottapel; Subburaj Ilangumaran; Christopher Neale; Jose La Rose; Jenny M-Y Ho; Melody H-H Nguyen; Dwayne Barber; Patrice Dubreuil; Paulo de Sepulveda
Journal:  Oncogene       Date:  2002-06-27       Impact factor: 9.867

3.  Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.

Authors:  Akio Matsuda; Yutaka Suzuki; Goichi Honda; Shuji Muramatsu; Osamu Matsuzaki; Yukiko Nagano; Takahiro Doi; Kunitada Shimotohno; Takeshi Harada; Eisuke Nishida; Hiroshi Hayashi; Sumio Sugano
Journal:  Oncogene       Date:  2003-05-22       Impact factor: 9.867

4.  SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.

Authors:  H Yoshikawa; K Matsubara; G S Qian; P Jackson; J D Groopman; J E Manning; C C Harris; J G Herman
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

5.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.

Authors:  G M Wulf; A Ryo; G G Wulf; S W Lee; T Niu; V Petkova; K P Lu
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

6.  Subcellular distribution of proteasomes implicates a major location of protein degradation in the nuclear envelope-ER network in yeast.

Authors:  C Enenkel; A Lehmann; P M Kloetzel
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

7.  Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.

Authors:  A Bierhaus; S Schiekofer; M Schwaninger; M Andrassy; P M Humpert; J Chen; M Hong; T Luther; T Henle; I Klöting; M Morcos; M Hofmann; H Tritschler; B Weigle; M Kasper; M Smith; G Perry; A M Schmidt; D M Stern; H U Häring; E Schleicher; P P Nawroth
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

8.  Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators.

Authors:  R Donald; D W Ballard; J Hawiger
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

9.  A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.

Authors:  Tewis Bouwmeester; Angela Bauch; Heinz Ruffner; Pierre-Olivier Angrand; Giovanna Bergamini; Karen Croughton; Cristina Cruciat; Dirk Eberhard; Julien Gagneur; Sonja Ghidelli; Carsten Hopf; Bettina Huhse; Raffaella Mangano; Anne-Marie Michon; Markus Schirle; Judith Schlegl; Markus Schwab; Martin A Stein; Andreas Bauer; Georg Casari; Gerard Drewes; Anne-Claude Gavin; David B Jackson; Gerard Joberty; Gitte Neubauer; Jens Rick; Bernhard Kuster; Giulio Superti-Furga
Journal:  Nat Cell Biol       Date:  2004-01-25       Impact factor: 28.824

10.  A lymphotoxin-driven pathway to hepatocellular carcinoma.

Authors:  Johannes Haybaeck; Nicolas Zeller; Monika Julia Wolf; Achim Weber; Ulrich Wagner; Michael Odo Kurrer; Juliane Bremer; Giandomenica Iezzi; Rolf Graf; Pierre-Alain Clavien; Robert Thimme; Hubert Blum; Sergei A Nedospasov; Kurt Zatloukal; Muhammad Ramzan; Sandra Ciesek; Thomas Pietschmann; Patrice N Marche; Michael Karin; Manfred Kopf; Jeffrey L Browning; Adriano Aguzzi; Mathias Heikenwalder
Journal:  Cancer Cell       Date:  2009-10-06       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.